Ceragon Networks (NASDAQ:CRNT – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Ceragon Networks (NASDAQ:CRNT – Get Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The communications equipment provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. Ceragon Networks had a return on equity of 9.95% and a net margin of 1.79%. The business had revenue of $90.36 million for the quarter. During the same period in the prior year, the firm posted ($0.01) EPS.
Ceragon Networks Stock Down 1.8 %
CRNT stock traded down $0.05 during midday trading on Tuesday, hitting $2.77. The company’s stock had a trading volume of 29,325 shares, compared to its average volume of 569,785. The stock’s 50-day moving average price is $2.99 and its 200 day moving average price is $2.41. Ceragon Networks has a 1 year low of $1.56 and a 1 year high of $3.38. The stock has a market cap of $236.61 million, a price-to-earnings ratio of 40.29 and a beta of 1.48.
Analyst Ratings Changes
Read Our Latest Research Report on CRNT
Ceragon Networks Company Profile
Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. The company's solutions use microwave and millimeter wave radio technology to transfer telecommunication traffic between base stations, small/distributed cells, and the service provider's network.
Featured Articles
- Five stocks we like better than Ceragon Networks
- 3 REITs to Buy and Hold for the Long Term
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is a Special Dividend?
- Hilton Demonstrates Asset Light is Right for Investors
- Why Are Stock Sectors Important to Successful Investing?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Ceragon Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceragon Networks and related companies with MarketBeat.com's FREE daily email newsletter.
